Overview

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

Status:
Completed
Trial end date:
2018-12-10
Target enrollment:
Participant gender:
Summary
A Phase 2 study evaluating safety, tolerability, and efficacy of SNA-120 ointment when administered topically with calcipotriene ointment for the treatment of pruritus and psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Sienna Biopharmaceuticals
Treatments:
Calcipotriene
Calcitriol